cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Novocure Limited
42 own
25 watching
Current Price
$26.33
$0.1
(0.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,375.23M
52-Week High
52-Week High
34.13000
52-Week Low
52-Week Low
11.70000
Average Volume
Average Volume
1.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
1592.0101
iconMarket Capitalization1,375.23M
icon52-Week High34.13000
icon52-Week Low11.70000
iconAverage Volume1.4M
iconDividend Yield--
iconP/E Ratio1592.0101
What does the Novocure Limited do?
Markets a wearable electric field device for treating glioblastoma brain cancer.
Read More
How much money does Novocure Limited make?
News & Events about Novocure Limited.
Globe Newswire
1 year ago
Did you lose money on investments in NovoCure Limited? If so, please visit NovoCure Limited Shareholder Class Action Lawsuit or contactPeter Allocco at (212) 951-2030orpallocco@bernlieb.com to discuss your rights. NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally ...
Globe Newswire
1 year ago
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLPreminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired NovoCure Limited (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023. NovoCure Limited is an ...
Globe Newswire
1 year ago
LOS ANGELES, July 05, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingAugust 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NovoCure Limited (NovoCure or the Company) (...
Globe Newswire
1 year ago
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed againstNovoCure Limited (NovoCure or the Company) (NASDAQ: NVCR) and certain of its officers. Class ...
Business Wire
1 year ago
National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (NovoCure or the Company) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us...
Frequently Asked Questions
Frequently Asked Questions
What is Novocure Limited share price today?
plus_minus_icon
Can Indians buy Novocure Limited shares?
plus_minus_icon
How can I buy Novocure Limited shares from India?
plus_minus_icon
Can Fractional shares of Novocure Limited be purchased?
plus_minus_icon
What are the documents required to start investing in Novocure Limited stocks?
plus_minus_icon
What is today’s traded volume of Novocure Limited?
plus_minus_icon
What is today’s market capitalisation of Novocure Limited?
plus_minus_icon
What is the 52-Week High and Low Range of Novocure Limited?
plus_minus_icon
What percentage is Novocure Limited down from its 52-Week High?
plus_minus_icon
What percentage is Novocure Limited up from its 52-Week Low?
plus_minus_icon
Current Price
$26.33
$0.1
(0.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$33.28
$-0.04 (-0.12 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$1.74
$-0.11 (-5.95 %)
Nevro Corp
Nevro Corp
$4.25
$0.55 (14.86 %)
Xencor Inc
Xencor Inc
$20.05
$0.94 (4.92 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$33.28
$-0.04 (-0.12 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$1.74
$-0.11 (-5.95 %)
Nevro Corp
Nevro Corp
$4.25
$0.55 (14.86 %)
Xencor Inc
Xencor Inc
$20.05
$0.94 (4.92 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00